Thu, Jul 24, 2014, 11:42 AM EDT - U.S. Markets close in 4 hrs 18 mins

Recent

% | $
Click the to save as a favorite.

Valeant Pharmaceuticals International, Inc. Message Board

  • jimkolak jimkolak Apr 4, 2011 1:24 PM Flag

    Once CEPH deal is done

    VRX will will be taken over.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I have a couple problems with your post that "VRX will be taken over" after the CEPH deal is done.

      1. Who ends up buying CEPH? You do not indicte who the buyer is. I don't think that it will be VRX. And if it is VRX, it will be at a price much higher than their ridiculous $74 offer.

      2. I am sure that VRX management would love to sell their debt and suspicious intangible asset loaded balance sheet to some idiotic large cap pharma buyer. I persoanlly do not think that anyone would ever buy VRX, given how crappy the company is. And if a large cap pharma company wants to get CEPH, why not bid now for CEPH against VRX and win easily - as opposed to having to buy VRX (with CEPH folded in) at a later date. VRX does not have the financial muscle to get into a bidding war. Despite my concerns, you do not indicate what "price" you think VRX will be sold. If VRX is sold, I think that it will be after the company's share price gets crushed due to company mismanagement and overvaluation.

 
VRX
125.15+0.53(+0.43%)11:42 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.